Griffith University viral immunologist Professor Suresh Mahalingam has been appointed to a World Health Organization (WHO) advisory group tasked with combatting viruses like dengue and Zika.
A next-generation COVID-19 mucosal vaccine is set to be a gamechanger not only when delivering the vaccine itself, but also for people who are needle-phobic.
Underlying evolutionary dynamics could play a key role in the replication and progress of the chikungunya virus, a mosquito-borne viral disease.
Researchers are investigating whether the COVID virus can affect vision and depth-perception of those infected.
An international collaboration of researchers from Griffith University’s Menzies Health Institute Queensland, the University of Tartu, the University of Glasgow...
Griffith University has been named as a Global Virus Network Centre of Excellence, one of three in Australia.
Griffith University researchers have partnered with a leading vaccines manufacturing company based in Hyderabad, India to develop a vaccine for COVID-19.
A new Griffith University study aims to develop drugs to treat alphavirus infection such as Ross River, Chikungunya, O’nyong’nyong and...
Griffith University research projects have received more than $6 million in funding from the National Health and Medical Research Council
NHMRC funding for Griffith researcherstotals $5,167,963.
